These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37248680)

  • 21. Identification of darbepoetin alfa in human plasma by liquid chromatography coupled to mass spectrometry for doping control.
    Guan F; Uboh CE; Soma LR; Birksz E; Chen J
    Int J Sports Med; 2009 Feb; 30(2):80-6. PubMed ID: 19177313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doping control analysis of 46 polar drugs in horse plasma and urine using a 'dilute-and-shoot' ultra high performance liquid chromatography-high resolution mass spectrometry approach.
    Kwok WH; Choi TLS; Kwok KY; Chan GHM; Wong JKY; Wan TSM
    J Chromatogr A; 2016 Jun; 1451():41-49. PubMed ID: 27180888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine metabolism of the growth hormone secretagogue MK-0677 in vitro and in urine and plasma following oral administration.
    Cutler C; Viljanto M; Taylor P; Habershon-Butcher J; Van Eenoo P
    Drug Test Anal; 2022 Jul; 14(7):1273-1290. PubMed ID: 35302297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the metabolism of the selective androgen receptor modulator LGD-4033 in equine urine, plasma and hair following oral administration.
    Cutler C; Viljanto M; Hincks P; Habershon-Butcher J; Muir T; Biddle S
    Drug Test Anal; 2020 Feb; 12(2):247-260. PubMed ID: 31655494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry.
    Vogel M; Dib J; Tretzel L; Piper T; Thomas A; Schänzer W; Thevis M
    Anal Bioanal Chem; 2016 Sep; 408(23):6431-42. PubMed ID: 27438721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity.
    Johnson DL; Farrell FX; Barbone FP; McMahon FJ; Tullai J; Kroon D; Freedy J; Zivin RA; Mulcahy LS; Jolliffe LK
    Chem Biol; 1997 Dec; 4(12):939-50. PubMed ID: 9427659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Label-free Proteomics for Discovering Biomarker Candidates for Controlling Krypton Misuse in Castrated Horses (Geldings).
    Wong KS; Cheung HW; Choi TLS; Kwok WH; Curl P; Mechie SC; Prabhu A; Wan TSM; Ho ENM
    J Proteome Res; 2020 Mar; 19(3):1196-1208. PubMed ID: 32050764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro metabolism of tiletamine, zolazepam and nonbenzodiazepine sedatives: Identification of target metabolites for equine doping control.
    Fenwick SJ; Scarth JP
    Drug Test Anal; 2011 Oct; 3(10):705-16. PubMed ID: 21916022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doping control study of AICAR in post-race urine and plasma samples from horses.
    Wong JKY; Kwok WH; Chan GHM; Choi TLS; Ho ENM; Jaubert M; Bailly-Chouriberry L; Bonnaire Y; Cawley A; Ming Williams H; Keledjian J; Brooks L; Chambers A; Lin Y; Wan TSM
    Drug Test Anal; 2017 Sep; 9(9):1363-1371. PubMed ID: 28407446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
    Kwok WH; Ho EN; Lau MY; Leung GN; Wong AS; Wan TS
    Anal Bioanal Chem; 2013 Mar; 405(8):2595-606. PubMed ID: 23318763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation and identification of recombinant human erythropoietin and darbepoetin Alfa in equine plasma by LC-MS/MS for doping control.
    Guan F; Uboh CE; Soma LR; Birks E; Chen J; You Y; Rudy J; Li X
    Anal Chem; 2008 May; 80(10):3811-7. PubMed ID: 18380469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic studies of formestane in horses.
    Leung GN; Kwok WH; Wan TS; Lam KK; Schiff PJ
    Drug Test Anal; 2013 Jun; 5(6):412-9. PubMed ID: 23339113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of anabolic and androgenic steroids and/or their esters in horse hair using ultra-high performance liquid chromatography-high resolution mass spectrometry.
    Kwok KY; Choi TLS; Kwok WH; Wong JKY; Wan TSM
    J Chromatogr A; 2017 Apr; 1493():76-86. PubMed ID: 28314523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1.
    Johnson DL; Farrell FX; Barbone FP; McMahon FJ; Tullai J; Hoey K; Livnah O; Wrighton NC; Middleton SA; Loughney DA; Stura EA; Dower WJ; Mulcahy LS; Wilson IA; Jolliffe LK
    Biochemistry; 1998 Mar; 37(11):3699-710. PubMed ID: 9521688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equine in vivo metabolite profiling of the selective androgen receptor modulator LGD-3303 for doping control.
    Broberg MN; Knych H; Bondesson U; Pettersson C; Tidstedt B; Stanley S; Thevis M; Hedeland M
    J Pharm Biomed Anal; 2023 Sep; 233():115468. PubMed ID: 37224728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive solid-phase extraction of multitudinous bioactive peptides from equine plasma and urine for doping detection.
    Guan F; Robinson MA
    Anal Chim Acta; 2017 Sep; 985():79-90. PubMed ID: 28864198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Droplet Digital PCR Detection of the Erythropoietin Transgene from Horse Plasma and Urine for Gene-Doping Control.
    Tozaki T; Ohnuma A; Takasu M; Kikuchi M; Kakoi H; Hirota KI; Kusano K; Nagata SI
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30901981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide.
    Middleton SA; Barbone FP; Johnson DL; Thurmond RL; You Y; McMahon FJ; Jin R; Livnah O; Tullai J; Farrell FX; Goldsmith MA; Wilson IA; Jolliffe LK
    J Biol Chem; 1999 May; 274(20):14163-9. PubMed ID: 10318834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxy levamisole and its phase II conjugates as potential indicators of levamisole doping in thoroughbred horses.
    Philip M; Karakka Kal AK; Subhahar MB; Karatt TK; Mathew B; Perwad Z; Graiban FM; Caveney MR; Sayed R; Kadry AM
    Rapid Commun Mass Spectrom; 2023 Feb; 37(3):e9430. PubMed ID: 36382989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.